Tag: Competition

Displaying 1381 - 1400 of 2424 results.

Pages

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Koninklijke Ahold N.V.'s proposed acquisition of Genuardi's supermarkets would have been anticompetitive in the local grocery market in Newtown, Pennsylvania. The final order resolving...
The Federal Trade Commission and the Department of Justice announced today that they will hold a joint public workshop on most-favored-nation clauses (MFNs) on Sept.10, 2012, to explore the use of MFN clauses and the implications for antitrust enforcement and policy. 
The Federal Trade Commission is seeking public comments on proposed changes to the premerger notification rules that could require companies in the pharmaceutical industry to report proposed acquisitions of exclusive patent rights to the FTC and the Department of Justice for antitrust review. The...
The Federal Trade Commission's Bureau of Competition staff has issued an advisory opinion letter, in response to a request from the Generic Pharmaceutical Association (GPhA), stating that the staff will not recommend a challenge to an initiative intended to help the U.S. Food and Drug...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Johnson & Johnson's proposed acquisition of Synthes, Inc. would have been anticompetitive in the market for surgical systems used to treat traumatic distal radius wrist fractures....
Renown Health agreed to settle charges that its acquisitions of two local cardiology groups reduced competition for the provision of adult cardiology services in the Reno area. Renown Health, based in Reno, Nevada, operates general acute care hospitals and commercial health plans...
Renown Health, the largest provider of acute care hospital services in northern Nevada, will release its staff cardiologists from "non-compete" contract clauses, allowing up to 10 of them to join competing cardiology practices. Renown Health has agreed to settle Federal Trade Commission charges...
Federal Trade Commission Chairman Jon Leibowitz today announced four appointments to leadership positions in the agency. Andrew I. Gavil will join the FTC from Howard University School of Law and serve as Director of the Office of Policy Planning (OPP), and Steven M. Bellovin, from Columbia...
The Federal Trade Commission has withdrawn the Policy Statement on Monetary Equitable Remedies in Competition Cases. The Statement was issued in 2003 and outlined a framework for determining when the Commission would seek equitable monetary remedies, such as disgorgement of ill-gotten gains, in...
The Federal Trade Commission will require drug supplier Novartis AG to give up its marketing rights to four topical skin care medications, under a proposed settlement resolving charges that Novartis' acquisition of pharmaceutical firm Fougera Holdings, Inc. would harm competition in the market...
The FTC required drug supplier Novartis AG to give up its marketing rights to four topical skin care medications, under a settlement resolving charges that Novartis' acquisition of pharmaceutical firm Fougera Holdings, Inc. would harm competition in the market for these topical drugs...
Federal Trade Commission Commissioner Edith Ramirez issued the following statement regarding this week's ruling by the U.S. Court of Appeals for the Eleventh Circuit, which upheld the FTC's Opinion and Order in the matter of Polypore International, Inc.
The Federal Trade Commission expressed concern to Congress about the prospect that companies that own "standard-essential" patents which are subject to commitments to license on reasonable and non-discriminatory terms may be able to "hold up" other firms by obtaining an injunction or exclusion...
Following a public comment period, the Federal Trade Commission has approved an amended final order settling charges that Teva Pharmaceutical Industries, Ltd.'s proposed acquisition of rival Cephalon, Inc. would have been anticompetitive in the markets for several current and future generic drugs...
On Tuesday, October 2, 2012, the Federal Trade Commission will host a workshop to examine the ways pet medications are distributed to consumers, and how these practices affect consumer choice and price competition. It is estimated that 62 percent of American households own a pet, and that pet...
The Federal Trade Commission has closed its nonpublic investigation of Sony/ATV Music Publishing's proposed acquisition of EMI Music Publishing, without taking any action. Accordingly, the deal may now proceed as proposed. The Commission vote to close the investigation was 5-0. The closing letters...
Following a public comment period, the Federal Trade Commission has issued a modified final order settling charges that Perrigo Company's $540 million acquisition of Paddock Laboratories, Inc., as proposed, was anticompetitive and would have reduced the number of manufacturers for four products...
The Federal Trade Commission will require Koninklijke Ahold N.V., the parent company of Giant Food Stores, LLC, to sell a supermarket outside of Philadelphia, Pennsylvania, to settle charges that its proposed acquisition of the Genuardi's supermarket chain from Safeway Inc. otherwise would be...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Kinder Morgan Inc.'s proposed acquisition of El Paso Corporation would have been anticompetitive in several natural gas pipeline transportation and gas processing markets. The final FTC...

Pages